Top compounds associated with response to NME4


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.4
mRNA silmitasertib CTRPv2 pan-cancer AAC -0.032 0.4
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC -0.16 0.4
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA A-804598 CTRPv2 pan-cancer AAC -0.039 0.4
mRNA salermide CTRPv2 pan-cancer AAC 0.038 0.4
mRNA compound 1B CTRPv2 pan-cancer AAC -0.033 0.4
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.028 0.4
mRNA Compound 1541A CTRPv2 pan-cancer AAC -0.032 0.4
Download CSV